Literature DB >> 11413094

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)-executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions.

S C Smith1, J T Dove, A K Jacobs, J W Kennedy, D Kereiakes, M J Kern, R E Kuntz, J J Popma, H V Schaff, D O Williams, R J Gibbons, J P Alpert, K A Eagle, D P Faxon, V Fuster, T J Gardner, G Gregoratos, R O Russell, S C Smith1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11413094     DOI： 10.1161/01.cir.103.24.3019

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  100 in total

Review 1.  A guide to drug use during percutaneous coronary intervention.

Authors:  Joseph K Choo; John J Young; Dean J Kereiakes
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Interventional versus conservative treatment in acute non-ST elevation coronary syndrome: time course of patient management and disease events over one year in the RITA 3 trial.

Authors:  P A Poole-Wilson; S J Pocock; K A A Fox; R A Henderson; D J Wheatley; D A Chamberlain; T R D Shaw; T C Clayton
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

3.  Quality improvement guidelines for the performance of cervical carotid angioplasty and stent placement.

Authors:  John D Barr; John J Connors; David Sacks; Joan C Wojak; Gary J Becker; John F Cardella; Bohdan Chopko; Jacques E Dion; Allan J Fox; Randall T Higashida; Robert W Hurst; Curtis A Lewis; Terence A S Matalon; Gary M Nesbit; J Arliss Pollock; Eric J Russell; David J Seidenwurm; Robert C Wallace
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

4.  Translational research: current status, challenges and future strategies.

Authors:  Dale Yu
Journal:  Am J Transl Res       Date:  2011-09-12       Impact factor: 4.060

5.  Gender differences in satisfaction with life in patients with coronary heart disease: physical activity as a possible mediating factor.

Authors:  Lisa A McDonnell; Dana L Riley; Chris M Blanchard; Robert D Reid; Andrew L Pipe; Louise I Morrin; Louise J Beaton; Sophia Papadakis; Monika E Slovinec D'Angelo
Journal:  J Behav Med       Date:  2010-10-19

6.  Percutaneous coronary intervention outcomes in US hospitals with varying structural characteristics: analysis of the NCDR®.

Authors:  Peter Cram; John A House; John C Messenger; Robert N Piana; Phillip A Horwitz; John A Spertus
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

7.  Indications for percutaneous coronary interventions performed in US hospitals: a report from the NCDR®.

Authors:  Peter Cram; John A House; John C Messenger; Robert N Piana; Phillip A Horwitz; John A Spertus
Journal:  Am Heart J       Date:  2012-02       Impact factor: 4.749

Review 8.  The role of PCI and CABG in the management of coronary artery disease in patients with diabetes.

Authors:  Robert L Frye; Malcolm R Bell; Hartzell V Schaff; Richard Holubkov; Katherine M Detre
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  New scoring model (DARSYM score) to predict post-discharge bleeding after successful second-generation drug-eluting stent implantation.

Authors:  Yohsuke Honda; Masahiro Yamawaki; Keisuke Hirano; Motoharu Araki; Norihiro Kobayashi; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutumi; Takuro Takama; Takahiro Tokuda; Kenji Makino; Shigemitsu Shirai; Yoshiaki Ito
Journal:  Heart Vessels       Date:  2017-05-30       Impact factor: 2.037

10.  Towards patient-specific risk assessment of abdominal aortic aneurysm.

Authors:  M Breeuwer; S de Putter; U Kose; L Speelman; K Visser; F Gerritsen; R Hoogeveen; R Krams; H van den Bosch; J Buth; T Gunther; B Wolters; E van Dam; F van de Vosse
Journal:  Med Biol Eng Comput       Date:  2008-09-23       Impact factor: 2.602
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.